Adam R Craig Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam R Craig.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam R Craig. Adam R Craig is a President and CEO in CTI BIOPHARMA CORP ($CTIC) and a See Remarks in CTI BIOPHARMA CORP ($CTIC) and a EVP, Development & CMO in SUNESIS PHARMACEUTICALS INC ($SNSS) and a VP and Chief Medical Officer in CytRx Oncology Corp ($NA).
Address: 555 MADISON AVENUE 25TH FLOOR NEW YORK 10022 NY
Companies in which Adam R Craig is an Insider
CTI BIOPHARMA CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam R Craig: President and CEO, See Remarks
Holdings: 5,000 shares
Current Value: $23,350
Latest Transaction: Mar 12 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytRx Oncology Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Adam R Craig: VP and Chief Medical Officer
Holdings: 0 shares
Latest Transaction: Jul 23 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viracta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam R Craig: EVP, Development & CMO
Holdings: 23,452 shares
Current Value: $96,153
Latest Transaction: Mar 02 2015
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Adam R Craig
Sentiment: All, CTIC, NA, SNSS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 3.30 | 800,000 | 2,640,000 | 800,000 | |
| Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Grant | A | 0.98 | 5,000 | 4,900 | 5,000 | 0 to 5 K |
| Mar 13 2020 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 1.00 | 2,320,000 | 2,320,000 | 2,320,000 | |
| May 20 2019 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 0.84 | 1,300,000 | 1,093,430 | 1,300,000 | |
| Sep 20 2018 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 1.88 | 600,000 | 1,128,000 | 600,000 | |
| May 17 2018 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 4.14 | 475,000 | 1,966,500 | 475,000 | |
| Oct 03 2017 | CTIC | CTI BIOPHARMA CORP | Craig Adam R | President and CEO | Option Exercise | A | 3.19 | 450,000 | 1,435,500 | 450,000 |